Heart failure in Eastern Veneto: Prevalence, hospitalization rate, adherence to guidelines and social costs;Lo scompenso cardiaco nel Veneto Orientale: Prevalenza, ospedalizzazione, aderenza alle linee guida e costi sociali

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 66, Issue 1, 2006, Pages 63-74

  Valle, Roberto ^g,h   Baccichetto, Renzo ^a   Barro, Sabrina ^g   Calderan, Alessandro ^b   Carbonieri, Emanuele ^c   Chinellato, Maura ^d   Chiatto, Mario ^e   D'Eri, Alessandra ^g   Corazza, Francesco ^b   D'Atri, Massimo ^f   Drigo, Raffaela ^f   Fabris, Simeone ^d   Gelli, Giuseppe Fabris ^b   Giudice, Antonio Lo ^b   Noventa, Federica ^g   Pollon, Alessandro ^a   Santin, Paolo ^a   Zanardi, Franco ^f   Milani, Loredano ^g  

^a Distretto Socio Sanitario di Base n 2   (Italy)

^b Distretto Socio Sanitario di Base n 1   (Italy)

^c Centro per la Prevenzione delle Malattie Cardiovascolari UO Cardiologia   (Italy)

^d Distretto Socio Sanitario di Base n 3   (Italy)

^e UO Cardiologia   (Italy)

^f ASL   (Italy)

^g Centro per lo Scompenso Cardiaco   (Italy)

^h NONE

Author keywords

Cost of illness; Heart failure; Hospitalisation rates; Prevalence

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOLOGIST; CONSULTATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DATA BASE; ECHOCARDIOGRAPHY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH SURVEY; HEART FAILURE; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PATIENT REFERRAL; PATIENT SATISFACTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; REPRODUCIBILITY;

EID: 33751202950     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2006.542     Document Type: Article

References (63)

1. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-205.
2. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
3. Ambrosio GB, Casiglia E, Spolaore P, et al. Prevalence of heart failure in the elderly. A survey from a population in the Veneto Region. Acta Cardiol 1994; 49: 324-327.
4. Misuraca G, Serafini O, Caporale R, et al. Prevalenza e caratteristiche cliniche dell'insufficienza cardiaca in un campione di popolazione della Calabria. G Ital Cardiol 1998; 28: 1385-90.
5. Di Lenarda A, Goliani P, Grella M, et al. Le statistiche ospedaliere come strumento di studio epidemiologico: lo scompenso cardiaco a Trieste. Ital Heart J Suppl. 2002; 3: 58-70.
6. Badano L, Di Lenarda A, Bellotti P, et al. Patients with chronic heart failure encounterd in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials. Ital Heart J 2003; 4: 84-91.
7. Mangia R, Senni M, Cacciatore G, et al. È tempo di organizzare una "nuova" lotta allo scompenso cardiaco? Ital Heart J Suppl 2003; 4: 232-236.
8. CIBIS-II Investigators and Committees. The Cardiac insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.
9. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 734-740.
10. Packer M, Bristow MR, Cohn IN, et al, for the US Carvedilol Heart Failure Study Group. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
11. Pitt B, Zannad F, Remmie WJ, et al. The effects of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717.
12. CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
13. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302.
14. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533.
15. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW 2000. Metodi per la valutazione dei programmi sanitari. Il Pensiero Scientifico Editore.
16. Cavallo MC, Fattore G. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord 1997; 11: 184-90
17. Parameshwar J, Shackel MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in north-west London. Br J Gen Pract 1992; 42: 287-289.
18. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Practice 1996; 46: 77-79.
19. Clarke KW, Gray D, Hampton JR. How common is heart failure? Evidence from PACT (Prescribing Analysis and Cost) data in Nottingham. J Public Health Med 1995; 17: 459-464.
20. Sparrow N, Adlam D, Cowley A, Hampton JR. The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Failure 2003; 5: 349-354.
21. Task Force for the the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560.
22. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003; 289: 194-202.
23. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of CHF. The Framingham study. N Engl J Med 1971; 285: 1442-6.
24. Giunta regionale del Veneto. Relazione socio-sanitaria della Regione Veneto: anni 1998-99. Venezia 2001.
25. Regione del Veneto. Nomenclatore tariffario delle prestazioni specialistiche ambulatoriali. Venezia. 2002.
26. Banca d'Italia. I bilanci delle famiglie italiane nel 1998. Suppl Boll Stat 2000;22:9-10.
27. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community. A study of all incident cases in Olmsted county, Minnesota, in 1991. Circulation 1998; 98: 2282-2289.
28. Bellotti P, Badano LP, Acquarone N, Griffo R, Lo Pinto G, Maggioni A, Mattiauda C, Menardo G, Mombelloni P. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study. Eur Heart J 2001; 22: 596-604.
29. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds. The TEMISTOCLE study. Am Heart J 2003; 146: E12.
30. Valle R, Perina F, Canali C, et al. L'ospedalizzazione per scompenso cardiaco nel Veneto. Ital Heart J Suppl 2002; 3: 151.
31. Tarantini L, Faggiano P, Senni M, et al. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure. Ital Heart J 2002; 3: 656-664.
32. Rapezzi C. Il profilo di mortalità/morbidità ed i fattori predittivi. In: Atti del Convegno "Il database dell'Italian Network on Congestive Heart Failure (IN-CHF): risultati e prospettive". Napoli, 1999: 31-47.
33. Gronda E, Mangiavacchi M, Andreuzzi B, et al. A population-based study on overt heart failure in Lombardy (survey of hospitalization in 1996 and 1997). Ital Heart J 2002; 3: 96-103.
34. Milani L, Valle R. È tempo di organizzare una "nuova" lotta allo scompenso cardiaco? Ital Heart J Suppl 2003; 4 (Lettera): 774-775.
35. Valle R, Canali C, Giovinazzo P, et al. È possibile dimettere precocemente il paziente il paziente con scompenso cardiaco non complicato? Un'analisi costo-efficacia. Ital Heart J Suppl 2003; 4: 965-972.
36. Chinellato M. (ed.). Linee Guida aziendali per la gestione dello scompenso cardiaco. A.U.L.S. n. 10. San Donà di Piave - Portogruaro. Maggio - Giugno 2000.
37. Valle R, Chinellato M, Milani L. Le linee guida ASL per la gestione dello scompenso cardiaco: uno strumento per il perseguimento della continuità assistenziale tra ospedale e territorio. Atti del conv triveneto di Cardiologia. Trieste 8 aprile 2000; pp. 70-71.
38. AHA/ACC Conference Proceedings. Measuring and Improving Quality of Care. Circulation 2000; 101: 1483-1493.
39. Krumholz HM, Baker DW, Ashton CM, et al. Evaluating quality of care for patients with heart failure. Circulation Electronic Pages 2000; 10: e122-e140.
40. Tarantini L, Faggiano P, Cioffi G, Russo P, Catania G. Lo scompenso cardiaco diastolico alla ricerca di un'identità. Monaldi Arch Chest Dis 2003; 60: 79-84.
41. Frigerio M, Oliva F, Turazza MF, Bonow RO. Prevention and management of chronic heart failure in management of asymptomatic patients. Am J Cardiol 2003; 91 (suppl): 4F-9F.
42. Tarantini G, Aspromonte N, Di Lenarda A, et al. Come si formula la diagnosi di scompenso cardiaco nell'ambito della medicina generale? Osservazioni su un campione multicentrico di medici di base italiani. Ital Heart J Suppl 2004; 5: 132.
43. Khunti K, Hearnshaw H, Baker R, Grimshaw G. Heart failue in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Failure 2002; 4: 771-777.
44. Sharpe N. Translation of clinical trials results into practice. Eur Heart J 1998: 19 (Suppl.): L28-L32.
45. McMurray JJ, Petrie MC, Murdoch DR, Davie AP. 1998. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 19: P9-P16.
46. Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure to the National Helath Service in th U.K. Eur J Heart Fail 2002; 4: 361-371.
47. Malek M. Health economics of heart failure. Heart 1999; 82 (Suppl. IV): 11-13.
48. Philbin EF. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure. J Gen Intern Med 1999; 14: 130-135.
49. McAlister FA, Lawson FME, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001: 110: 378-384.
50. Weintraub WS, Kawabata H, Tran M, L'Italien G, Chen R. Influence of comorbidity on cost of care for heart failure. Am J Cardiol 2003; 91: 1001-1015.
51. Thom TJ, Kannel WB. Congestive heart failure: epidemiology and cost of illness. Dis Manage Health Outcomes 1997; 1: 75-83.
52. Bjorck-Linné A, Liedholm H, Jendteg S, Israelsson. Health care costs of heart failure: results from a randomised study of patient education. Eur J Heart Fail 2000; 2: 291-297.
53. Julien C, Leroux Y, Colin C. Approche médicoéconomique de l'insuffisance cardiaque. Un enjeu de santé publique. Etudes Eval Cardiovasc 1999; 6: 1-12.
54. Brown AM, Cleland J. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J 1998; 19: 1063-1069.
55. Cleland JF. Health economic consequences of the pharmacological treatment of heart failure. Eur J Heart Fail 1998; P32-P39.
56. Valle R, Carbonieri E, Tenderini PL, et al. Lo studio collaborativo VENETIA-HF. Una proposta di modello organizzativo per la gestione post-dimissione dei pazienti affetti da scompenso cardiaco. Ital Heart J Suppl 2004; 5: 282-291.
57. Cacciatore G, Menichelli M, Albi F, De Lio L, Boccanelli A. Efficacia di un programma integrato di gestione ambulatoriale del paziente con scompenso cardiaco cronico. G Ital Cardiol 1998; 28: 1106-1112.
58. Chinaglia A, Gaschino G, Asteggiano R, et al. Fattibilità ed efficacia di un programma di assistenza integrata tra ospedale e territorio basata su un ambulatorio infermieristico nella gestione dei pazienti con scompenso cardiaco. Risultati clinici a sei mesi e costi relativi. Ital Heart J Suppl 2002; 3: 532-538.
59. Di Lenarda A, Sabbadini G, Sinagra G. Modelli integrati tra ospedale e territorio per l'assistenza al paziente con scompenso cardiaco. Monaldi Arch Chest Dis 2002; 58: 135-139.
60. Albanese MC, Gubiani M, Cuzzato AL, et al. La gestione dello scompenso cardiaco cronico: caratteristiche cliniche ed assorbimento di risorse dei pazienti seguiti dal Medico di Medicina Generale. Studio pilota sul territorio della provincia di Udine (Italia). Monaldi Arch Chest Dis 2002; 58: 95-100.
61. Bonneux L, Barendregt JJ, Meeter K, et al. Estimating clinical morbidity due to iscaemic heart disease and congestive heart failure: the future rise of heart failure. Am J Publ Health 1994; 84: 20-28.
62. Eriksson H, Svardsudd K, Larsson B, et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989; 10: 647-56.
63. Landahl S, Svanborg A, Astrand K. Heart volume and the prevalence of certain common cardiovascular disorders at 70 and 75 years of age. Eur Heart J 1984; 4: 326-31.